Glbal Ultrasound Market is Expected to Reach USD 908.5 Million in 2019: Transparency Market Research

According to a new market report published by Transparency Market Research " Ultrasound Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2017" the global bone densitometers market was valued at USD 777.9 million in 2012 and is expected to grow at a CAGR of 3.3% from 2013 to 2019, to reach an estimated value of USD 908.5million in 2019.

Browse full report with TOC: http://www.transparencymarketresearch.com/ultrasound-market.html

Rise in the number of people suffering from chronic diseases is driving the demand for early diagnosis of disease, which is done through ultrasound. One of the primary applications of ultrasound is to produce images of human fetuses. The ultrasound market is expected to be at USD 4,817.8 million in 2012, which will reach USD 6,114.8 in 2017 at an estimated CAGR of 4.9% from 2012 to 2017. 

The Americas had the largest share in the ultrasound market, accounting for 38.5% in 2011 due to technological developments in ultrasound giving accurate results. The Americas will lead the market for gynecology ultrasound for the next five years. 

Browse full PDF with TOC: http://medicaldevicesreports.files.wordpress.com/2013/12/ultrasound-market-global-industry-analysis-size-share-growth-trends-and-forecast-2012-2017.pdf

Asia and countries of RoW such as South Africa and Egypt will exhibit the highest growth rate in the near future. Technological innovations in ultrasound are in an evolution phase in RoW. Rise in R&D investment by key players of healthcare and growth in medical tourism driven by low cost of healthcare services and investment of foreign players in the healthcare sector can enhance the ultrasound industry in RoW. 

This report provides a holistic view to the overall global ultrasound industry with 8 year market data & forecast based on following segmentation:

By Type

• Gynecology ultrasound

• Cardiac ultrasound

• Vascular ultrasound

Regions Covered

• Americas        

• Europe

• APAC

• RoW, which consists of Middle East and Africa

Blogs:

http://usamarketresearch.wordpress.com/

http://pharmaceuticalmarkets.wordpress.com/

http://medicaldevicesreports.wordpress.com/

Read more

Breast Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018

Transparency Market Research Report Add "Breast Pumps Market (Manual, Battery-powered and Electric Pumps) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018" to its database.

According to a new market report published by Transparency Market Research "Breast Pumps Market (Manual, Battery-powered and Electric Pumps) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018" in 2011, the global breast pumps market was valued at USD 0.62 billion and is expected to grow at a CAGR of 7.5% from 2012 to 2018, to reach an estimated value of USD 1.03 billion in 2018.

Browse the full report with TOC: http://www.transparencymarketresearch.com/breast-pumps-market.html

The growth of this market is driven by the rising birth rates globally and the rapidly growing world population. With changing lifestyles and an increase in the number of working women, the consumer base for breast pumps is expanding and so is the demand for these devices. Restructuring of the reimbursement policies, which requires insurance companies to cover the cost of breastfeeding devices and lactation counseling, will also help improve the uptake  of breast pumps. Increasing disposable incomes are strengthening the purchasing power of consumers and rising awareness about the benefits of breastfeeding will further help fuel market growth during the forecast period 2012 to 2018.

Electric pumps market is the fastest growing market segment with a CAGR of 11.9%. The preference for personal use electric pumps is expected to be the highest. In addition, the battery-powered pumps segment was the largest market segment in 2011 and will continue to be the leading segment till 2018, in terms of revenue.

Geographically, the North American region accounted for the largest market share in 2011. This is mainly due to the large consumer population, availability of advanced medical technologies, strong presence of leading market players and high purchasing power of consumers. However, with a high double digit CAGR of 17.1%, Asia will emerge as the fastest growing market due to the rapidly growing population, increasing awareness, rising disposable incomes and growing economies.

The global breast pumps market is highly consolidated and dominated by players such as Medela, Inc., Philips AVENT and Ameda Breastfeeding Solutions. Of these, Medela, Inc. accounted for the largest market share in 2011. Other small players in this market include Bailey Medical, Energizer Personal Care, LLC (Playtex Baby), Hygeia Medical Group, Lansinoh Laboratories, Inc. and Whittlestone, Inc.

The global breast pumps market is segmented as follows:
Breast Pumps Market, by Pumping System Type 
• Manual 
• Battery-powered 
• Electric 
• Personal Use 
• Hospital Grade 

Breast Pumps Market, by Product Design 
• Open System Pumps 
• Closed System Pumps 

Biopsy Devices Market, by Geography 
• North America 
• Europe 
• Asia 
• Rest of the World (RoW)

Blogs:
http://usamarketresearch.wordpress.com/
http://pharmaceuticalmarkets.wordpress.com/
http://medicaldevicesreports.wordpress.com/

Read more

Microturbine Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

According to a new market report published by Transparency Market Research "Microturbine Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" global microturbine systems market was valued at USD 144.4 million in 2012, growing at a CAGR of 16.7% from 2013 to 2019. Annual installation was 123.2 MW in 2012 and is expected to reach 447.4 MW in 2019, growing at a CAGR of 19.8% from 2013 to 2019.

Browse the full report with complete TOC: http://www.transparencymarketresearch.com/microturbines-market.html

Rising global energy demand with increasing grid instability is expected to bolster microturbine systems market growth over the next five to six years. Impending stringent environmental regulations to curb down harmful emissions accompanied by increased awareness about clean and green energy generation are further fuelling the product demand. Increasing electricity consumption in off grid areas is likely to create new opportunities for the market, as these systems can be installed at a number of remote locations owing to its compact size and reliability. Inception of supercritical CO2 (Organic Rankine Cycle) with 16% more efficiency than conventional microturbine systems is probable to lay down new opportunities for the market.

Major end use segments analyzed in this report include residential, commercial and industrial microturbine market. Low power rating requirements (30 KW to 200 KW) of commercial end use segment is expected to drive microturbine systems market over the coming years. As a result the commercial end use segment is expected to grow at a CAGR of 20.2% over the forecast period. Industrial end use segment dominated microturbines market in 2012 which accounted for 59.33% market share. Furthermore, the market is categorized as per CHP generation and standby power applications of which CHP generation accounting for more than 67.0% market share in 2012.

North America dominated the microturbine systems market, accounting for 42.82% of the overall market in 2012. United States, Canada and Mexico are the key regional markets in North America wherein the U.S. dominated the market in 2012 and is expected to continue its dominance over the coming years. Increasing carbon footprint and regulatory intervention of several environmental agencies including CAA (Clean Air Act) are likely to fuel product demand in North America. Restructured EU NEC (European Union National Emission Ceilings) policies have assisted the microturbine market prosper significantly over the past couple of years. Asia Pacific microturbine systems market is estimated to reach USD 61.1 million by 2019 while Rest of the World microturbine systems market is expected to grow at a CAGR of 19.6% from 2013 to 2019 owing to the strong supportive schemes made available by the Brazilian government and increased energy demand in off grid areas of Africa.

The key market participants in the industry include Capstone Turbine Corporation, FlexEnergy, Global Microturbine LLC, and NewEnCo. The report provides an overview of these companies followed by their financial revenue, business strategies, and recent developments.

This research analyzes and estimates the performance and market of microturbine systems in the global scenario, providing detailed trend analysis of the market by geography and comprehensive analysis of companies that are dealing in microturbine systems. The report presents a thorough assessment of the strategies followed by different stakeholders by segmenting the microturbine systems market as below:

Microturbine Systems Market: End Use Analysis

·         Industrial

·         Commercial

·         Residential

Microturbine Systems Market: Application Analysis

·         CHP Generation

·         Standby Power

Microturbine Systems Market: Regional Analysis

·         North America

·         Europe

·         Asia-Pacific

·         RoW (Rest of the World)

Blogs:

http://usamarketresearch.wordpress.com/

http://pharmaceuticalmarkets.wordpress.com/

http://medicaldevicesreports.wordpress.com/

Read more

Global Bone Densitometers Market is Expected to Reach USD 908.5 Million Globally in 2019: Transparency Market Research

According to a new market report published by Transparency Market Research "Bone Densitometers Market (DEXA, QCT, pDEXA, SEXA, pQCT, RA and QUS)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" the global bone densitometers market was valued at USD 777.9 million in 2012 and is expected to grow at a CAGR of 3.3% from 2013 to 2019, to reach an estimated value of USD 908.5million in 2019.

Browse full report with TOC: http://www.transparencymarketresearch.com/bone-densitometers-market.html

Bone densitometry is a non-invasive diagnostic technique which involves use of bone densitometers for quantitative measurement of bone mass or density. Over a past few decades, decrease in bone mass or density has been associated with the occurrence of fractures in future and thus bone density measurement has been considered as an indicator to predict fracture risk. Moreover, people with medications for corticosteroid treatment, cancer, eating disorders, amenorrhea and genetic disorders are also preferred for evaluation of bone mineral density.

Major improvements in diagnostic technology have been witnessed since last decade due to change in perception for osteoporotic disease, growing elderly population and high expenditure to society and healthcare agencies along with the adverse effects on patients across the globe. The advances in the technology are making it possible for early detection of disease before fracture occurs. With socio-economic development in many developing countries and rapid ageing of the population, osteoporosis has become one of the most prevalent and costly health problems in these regions. Growing ageing population combined with increased vitamin D deficient patients and rise in risk for osteoporosis in post-menopausal women contribute to the growth of this market particularly in emerging economies of Middle East, India, China and Japan. Moreover, technological advances in bone densitometers coupled with increase in access and recognition of these technologies in emerging market, such as China, Brazil, Japan and India will serve as an opportunity for investors to invest in.

The global market for bone densitometers has been studied from the perspective of currently widely accepted technologies and the major end users. Technologies are further segmented, based on axial and peripheral bone density measurement. Axial bone densitometers include dual energy X-ray absorptiometry and quantitative computed tomography. Peripheral bone densitometers include single energy X-ray absorptiometry, peripheral dual energy X-ray absorptiometry, radiographic absorptiometry, quantitative ultrasound and peripheral computed tomography. The endusers for bone densitometers include clinics and hospitals. Hospitals remain the major hub in most of the countries across the globe for bone densitometry diagnostics and devices.

It is expected that the global market for axial bone densitometers will grow at a CAGR of over 3% from 2013 to 2019.In 2012, axial DEXA accounted for the largest share by revenue at USD 297.8 million of the total bone densitometers market. However, due to the decrease in the reimbursement, the overall market revenue is expected to decline during the forecast period in the U.S and Europe. The market for axial QCT accounted for the second largest share at USD 182.9million, in 2012. Moreover, it is expected that the global market for peripheral QCT bone densitometers will grow at a CAGR of over 4% from 2013 to 2019, owing to its high sensitivity, portability of devices, lesser scanning time, with better precision and accuracy, and also less radiation exposure.

Geographically, North America dominated the global market for bone densitometers in terms of revenue generation and is expected to maintain its position throughout the forecast period. The adoption of DEXA systems, growing elderly population and consequent  rise in incidences of osteoporosis in the U.S., is expected to contribute to the leadership of the North American market. Europe was the second largest regional market for bone densitometers in 2012, owing to the increased demand for bone density measurement.

The global bone densitometers market is dominated by few major players includingGE Healthcare Ltd.,Hologic, Inc., CooperSurgical, Inc. and Diagnostic Medical Systems S.A. Theother key players in the bone densitometers marketinclude BeamMed Ltd.,CompuMed, Inc., Lone Oak Medical Technologies LLC and OsteometerMediTech, Inc.

The global bone densitometers market is segmented as follows:

Bone Densitometers Market, by Technology

·      Axial Bone Densitometers

§  Dual Energy X-Ray Absorptiometry (DEXA)

§  Quantitative Computed Tomography (QCT)

·      Peripheral Bone Densitometers

§  X-ray Absorptiometry

o  Peripheral Dual energy X-ray Absorptiometry (pDEXA)

o  Single Energy X-Ray Absorptiometry (SEXA)

§  Radiographic Absorptiometry (RA)

§  Quantitative Ultrasound (QUS)

§  Peripheral Quantitative Computed Tomography (pQCT)

Bone Densitometers Market, by End-users

·      Clinics

·      Hospitals

Bone Densitometers Market, by Geography

·      North America

·      Europe

·      Asia-Pacific

·      Rest of the World (RoW)

§  Latin America

§  Middle East

Blogs:

http://usamarketresearch.wordpress.com/

http://pharmaceuticalmarkets.wordpress.com

http://medicaldevicesreports.wordpress.com/

Read more

Anesthesia Devices Market and Respiratory Devices Market is Expected to Reach USD 21.6 Billion Globally in 2019: Transparency Market Research

According to a new market report published by Transparency Market Research "Anesthesia and Respiratory Devices Market (Anesthesia Workstation, Anesthesia Delivery Machines, Ventilators, Monitors, Nebulizers & Respiratory Inhalers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global anesthesia and respiratory devices market was valued at USD 11.2 billion in 2012 and is expected to grow at a CAGR of 9.8% from 2013 to 2019, to reach an estimated value of USD 21.6 billion in 2019.

Browse full report with TOC: http://www.transparencymarketresearch.com/anesthesia-respiratory-devices.html

A rise in healthcare expenditures witnessed globally has led to a shift in preference from hospital care to home care among patients. This rise in healthcare cost, compounded by the geriatric population, is driving the demand for portable medical diagnostic devices including respiratory and anesthesia devices. This has led to a visible shift in the use of respiratory and anesthesia devices from hospital operation set ups to home care healthcare monitoring. Moreover, a rise in respiratory diseases such as asthma, lung cancer, COPDs (Chronic Obstructive Pulmonary Diseases) and OSA (Obstructive Sleep Apnea) have triggered the growth of this market. There has also been an exponential rise in number of surgical procedures globally and this has led to a significant growth in demand for anesthesia devices and delivery machines. Growing healthcare cost containment pressure in the U.S. and the ongoing Euro crisis have caused a slump in the growth of these markets. Tax reforms coupled with increased regulatory compliance norms are also restraining the growth and profitability of top companies. The tax reform under question has proposed the levy of a 2.3% tax on the annual sale of all the medical devices manufacturers since beginning of this year i.e. 2013.

This has made it imperative for OEMs to tap the potential market in emerging economies such as India, China, Brazil and Russia. There has been significant growth in these emerging economies owing to increase healthcare awareness, rising disposable incomes and a rising middle class coupled with favorable insurance policies in these countries. This in turn is anticipated to make these regions the most attractive markets during the forecast period from 2011 to 2019.

Saturation in western countries, especially the U.S. and Europe, coupled with unfavorable taxation policies has negatively affected the growth of the market in these regions. Companies are now vying for growth in emerging markets namely India,China and Brazil. The major players in this industry are also facing stiff competition from the regional manufacturers of these countries. However, robust R&D and continuous innovation has helped the big players of this market to retain their strong position in the market. In addition manufacturers such as GE Healthcare, Philips Healthcare, Teleflex and Drager have created a strong brand image with high end quality products supporting their strong market position.

The report covers in-depth analysis of estimation of anesthesia and respiratory devices market, for the period from 2013 to 2019, considering 2012 as the base year for calculations. In addition, the current market dynamics including the drivers, restraints, trends and recent developments has been captured throughout the report. The respiratory devices market has been further bifurcated under respiratory devices, respiratory disposables and respiratory measurement devices. This market has been further segmented by the respective types of devices. The anesthesia devices market has been split broadly under anesthesia machines and disposables. 

Anesthesia devices include anesthesia machines and anesthesia disposables. The anesthesia machines account for the largest market of the total anesthesia devices market. The market for anesthesia delivery machines was valued to be the highest in year 2012. However, the anesthesia monitors market is expected to grow at a higher CAGR of above 8.0% from 2013 to 2019. The respiratory devices market includes respiratory equipments, disposables and respiratory measurement devices. The respiratory equipments include humidifiers, nebulizers, oxygen concentrators, positive airway pressure devices, ventilators and inhalers. The positive airway pressure devices market is expected to foresee the highest growth in the coming years of forecast from 2013 to 2019.

The geographic chapter spans the major regions including North America, Europe, Asia and ROW (Rest of World). Similarly, market share analysis for global market for respiratory and anesthesia devices together has been provided in the competitive landscape chapter. In addition we have also separately provided the market share analysis for respiratory and anesthesia devices respectively. Some of the major players in this market are GE Healthcare, Drager, Fischer & Paykel, Covidien, Teleflex Incorporated, Philips Healthcare, ResMed and others. These market players have been profiled on the basis of attributes such as company overview, recent developments, strategies adopted by the market leaders to ensure growth, sustainability financial overview and recent developments. Our chapter on recommendations provides an understanding of barriers to the market entry and success strategy to be considered for growth in this market. 

Blogs:

http://usamarketresearch.wordpress.com

http://medicaldevicesreports.wordpress.com/

Read more

Medical Tourism: Treatments, Markets and Health System Implications: A scoping review

Transparency Market Research is Published new Market Report "Medical Tourism Market (India, Thailand, Singapore, Malaysia, Mexico, Brazil, Taiwan, Turkey, South Korea, Costa Rica, Poland, Dubai and Philippines) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" The global medical tourism market was valued at USD 10.5 billion in 2012 and is estimated to reach a market worth USD 32.5 billion in 2019 at a CAGR of 17.9% from 2013 to 2019.

Browse the full report with complete TOC: http://www.transparencymarketresearch.com/medical-tourism.html

Medical tourism is defined as an act of travel of patients from their home country to other destinations for availing medical services. Rise in healthcare costs in developed countries coupled with the availability of high quality medical services at a low cost in developing countries have given a boost to the medical tourism industry. These medical services range from elective procedures such as cosmetic surgeries to complicated surgeries such as cardiac, orthopedics, neurosurgery and others. Significant growth in this industry is due to economic developments in developing countries that in turn has led to the growth in the medical industry and quality of medical services.

Rise in the healthcare expenditure in developed countries coupled with in the growing elderly population has also contributed to the gowth of the medical tourism across the globe. Economic crisis in the U.S. increased the number of uninsured population, consequently further triggering the growth of this market. Recently, there are approximately 50 million uninsured Americans that are willing to travel abroad for affordable and quality medical care. Globalization and improved communication technology act as a catalyst to boost the growth of this industry.

The development of medical tourism industry is based on several factors such as reduced cost of procedures, long waiting time and high demand for cosmetic surgeries. Medical travel is not only witnessed for intricate procedures but is also expanding due to growing demand for cosmetic and dental procedures since these are usually not reimbursed under regular health insurance policies. Patients travelling abroad can save from 30% to 90% on a procedure, including their travel expenditures, as compared to the medical costs in their own countries. Long waiting time is another factor which has substantially boosted the growth of this industry. Patients based in Canada and U.K travel to low cost destinations for their treatments in order to avoid long waiting periods in their own countries and receive timely access to serious ailments.

Medical tourism industry is dominated by the Asian region that has captured the maximum share of the market. This region is highly competitive owing to the presence of technologically advanced medical specialties, less stringent government regulations and attractive locations. Thailand and India are recognized internationally for their high end medical services and receive patients from across the globe. Singapore is renowned for its healthcare infrastructure and receives patients primarily for complex medical procedures. Thailand, India and Singapore accounted for approximately 60% of the total revenue of the Asian region in 2012. The Latin American countries such as Brazil and Mexico attract maximum number of patients from the U.S owing to the geographic proximity and cultural similarities. Similarly, growth in Turkey is witnessed on account of growing demand of cosmetic surgeries.

However, a paradigm shift in the market is seen owing to strong competition among the players of this industry. Malaysia is poised to have a significant growth in this market and is likely to emerge as a fastest growing country in terms of medical tourism with a CAGR of over 25% from 2013 to 2019. This advent in Malaysian medical tourism market is due to cost advantage over Thailand and Singapore. Moreover, rise in popularity of Malaysian region is attributed to many factors such as advanced healthcare infrastructure, highly skilled professionals, visa benefits and others. Additionally, robust government support for promotion of Malaysian medical tourism has propelled the growth in this nation.

Moreover, increase in the government initiatives and growing inclination of private sector hospitals towards medical tourism is further supplanting the growth of this market. Key healthcare providers in this industry include Apollo Hospitals Enterprise Ltd., Bumrumgrad International Hospital, Bangkok Medical Center, Prince Court Medical Center and others.

The Medical Tourism market is segmented as follows:

The global medical tourism market is segmented into the following categories:

• Medical Tourism Market, by Geography
• India
• Overview
• Cost Comparison of Procedures
• SWOT Analysis
• Government Support
• India Inbound Medical Tourism (No. of patients)
• India Medical Tourism: Top Revenue Contributing Country (%) (2012)
• Thailand
• Singapore
• Malaysia
• Mexico
• Brazil
• Turkey
• South Korea
• Taiwan
• Prospective Countries
• Costa Rica
• Poland
• Dubai
• Philippines

Read more

Cell Surface Markers Market is Expected to Reach USD 23.03 Billion Globally in 2019: Transparency Market Research

Transparency Market Research published new market report "Cell Surface Markers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" the global cell surface markers market was valued at USD 13.2 billion in 2012 and is expected to grow at a CAGR of 8.1% from 2013 to 2019, to reach an estimated value of USD 23.03 billion in 2019.

Browse the full report: http://www.transparencymarketresearch.com/cell-surface-markers-market.html

Cell surface markers are expressed on the surface of cells and function as identifiers of certain type of cells. The presence of cell markers also assists in the determination of cell type expression of specific receptors vital for biological response. Cell surface marker analysis is also essential in determination of experimental drug or ligand response. Rapid development in healthcare technology, growing preference for reduction of healthcare expenditure by lowering the cost of diagnosis, reduction in the risk of misdiagnosis, rapid and efficient decision making for therapies for specific diseases are some of the major factors which support the growing acceptance of cell surface marker analysis worldwide.

Browse full PDF with TOC: Cell Surface Markers Market

On the other hand, complexity of high-end flow cytometers and high cost of reagents, controls and analysis systems result into lowering the adoption of sophisticated cell marker analysis solutions, particularly in economically lagged countries. Increased market consolidation, simplification of analysis products, cost containment of such products and introduction of cheaper products in less developed markets are the major market strategies which are being adopted by the existing and emerging market players to sustain the cell surface markers market.

The global cell surface markers market can be categorized into instruments and reagents, kits and controls used for cell marker analysis. Flow cytometers and hematology analyzers are the prime cell marker analysis equipment used. Flow cytometry is the most prominently used tool for cell marker analysis. Availability of a wide range of flow cytometers and their efficacy in both research and drug discovery are the major factors driving the demand for flow cytometers. It is expected that the global market for flow cytometers will grow at a CAGR of more than 8% from 2013 to 2019 with a cumulative installed base of approximately over 85,000 units by 2019.

Disease diagnosis and identification and research and drug discovery are the two prime application areas of cell surface marker analysis. Cell markers analysis is essential in drug discovery and its use in R&D by pharmaceutical manufacturers and researchers widespread. Thus in terms of allocations, drug discovery and research segment is expected to dominate the global cell surface markers during the given period of forecast.

Geographically, North America is the dominant regional market for cell surface markers with almost half of the market share. Emerging countries of Asia-Pacific, Latin America and Middle-East are expected to undergo rapid market growth by 2019. Improvement in healthcare infrastructure and growing preference for safer and easier targeted therapies are the major factors which will fuel the market growth in these regions.

The cell surface markers market is highly fragmented and consists of many large and small players. The competition in this market is characterized by market consolidation activities, partnerships and intensive mergers and acquisitions. Some of the major companies in the cell surface markers market include Abbott Laboratories, Beckman Coulter, BD Biosciences, Bio-Rad, Seimens Healthcare, Nihon Kohden Corporation, Sysmex Corporation and Roche Diagnostics.

The global cell surface markers market is segmented as follows:

Cell Surface Markers Market, by Instruments and Reagents

• Flow Cytometers
• Hematology Analyzers
• Reagents and Kits

Cell Surface Markers Market, by Applications

• Disease Diagnosis and Identification
• Research and Drug Discovery

Cell Surface Markers Market, by Geography

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Read more